3.93
price down icon1.75%   -0.07
after-market Handel nachbörslich: 3.93
loading
Schlusskurs vom Vortag:
$4.00
Offen:
$4.05
24-Stunden-Volumen:
73,431
Relative Volume:
0.98
Marktkapitalisierung:
$83.41M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-12.94M
KGV:
-1.3838
EPS:
-2.84
Netto-Cashflow:
$-13.83M
1W Leistung:
-3.68%
1M Leistung:
+10.70%
6M Leistung:
+4.52%
1J Leistung:
+238.79%
1-Tages-Spanne:
Value
$3.83
$4.075
1-Wochen-Bereich:
Value
$3.46
$4.16
52-Wochen-Spanne:
Value
$1.19
$7.42

Aileron Therapeutics Inc Stock (ALRN) Company Profile

Name
Firmenname
Aileron Therapeutics Inc
Name
Telefon
(737) 802-1989
Name
Adresse
12407 N. MOPAC EXPY., AUSTIN, MA
Name
Mitarbeiter
3
Name
Twitter
@Aileron_org
Name
Nächster Verdiensttermin
2024-11-18
Name
Neueste SEC-Einreichungen
Name
ALRN's Discussions on Twitter

Aileron Therapeutics Inc Stock (ALRN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2017-07-24 Eingeleitet BofA/Merrill Buy
2017-07-24 Eingeleitet Jefferies Buy
2017-07-24 Eingeleitet William Blair Outperform

Aileron Therapeutics Inc Aktie (ALRN) Neueste Nachrichten

pulisher
Oct 31, 2024

Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma - StockTitan

Oct 31, 2024
pulisher
Oct 29, 2024

Short Interest in Aileron Therapeutics, Inc. (NASDAQ:ALRN) Drops By 14.2% - MarketBeat

Oct 29, 2024
pulisher
Oct 14, 2024

Short Interest in Aileron Therapeutics, Inc. (NASDAQ:ALRN) Increases By 15.8% - MarketBeat

Oct 14, 2024
pulisher
Oct 13, 2024

ALRNAileron Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 13, 2024
pulisher
Oct 12, 2024

Aileron Therapeutics to Present Previously Announced Data from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) at the 22nd International Colloquium on Lung and Airway Fibrosis - Lelezard

Oct 12, 2024
pulisher
Oct 02, 2024

University of Texas Texas AM Investment Management Co. Invests $4.93 Million in Aileron Therapeutics, Inc. (NASDAQ:ALRN) - MarketBeat

Oct 02, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Raises Holdings in Aileron Therapeutics, Inc. (NASDAQ:ALRN) - MarketBeat

Oct 01, 2024
pulisher
Sep 28, 2024

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Down 13.4% in September - MarketBeat

Sep 28, 2024
pulisher
Sep 25, 2024

Alumis (NASDAQ:ALMS) Trading 4.8% Higher - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Keeping an Eye on Alx Oncology Holdings Inc (ALXO) After Insider Trading Activity - Knox Daily

Sep 25, 2024
pulisher
Sep 25, 2024

Ready to Jump After Recent Trade: Alx Oncology Holdings Inc (ALXO) - SETE News

Sep 25, 2024
pulisher
Sep 24, 2024

ALXO stock touches 52-week low at $1.87 amid market challenges - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

Alumis (NASDAQ:ALMS) Shares Gap Down to $11.86 - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Market Highlights: Alector Inc (ALEC) Ends on a Low Note at 5.45 - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

What is the investor’s view on Alx Oncology Holdings Inc (ALXO)? - US Post News

Sep 24, 2024
pulisher
Sep 23, 2024

Insider Sale Alert: Aldeyra Therapeutics Inc [ALDX] – Is it Time to sell? - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Alector (NASDAQ:ALEC) Shares Down 5.6% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) - Nasdaq

Sep 23, 2024
pulisher
Sep 23, 2024

Market Update: Alx Oncology Holdings Inc (ALXO) Sees Negative Movement, Closing at 2.07 - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Keith Johns Joins Allurion's Board Of Directors - MPO-mag

Sep 23, 2024
pulisher
Sep 23, 2024

HighVista Strategies LLC Makes New Investment in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Taking on analysts’ expectations and winning: Alumis Inc. (ALMS) - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Healius sells Lumus imaging unit to Affinity for USD 657M - Medical Buyer

Sep 23, 2024
pulisher
Sep 22, 2024

Australia Medical Diagnostics Firm Healius Sells Lumus to Affinity for $657 Million - BNN Bloomberg

Sep 22, 2024
pulisher
Sep 22, 2024

Renaissance Technologies LLC Sells 800 Shares of Alexander’s, Inc. (NYSE:ALX) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Alector (NASDAQ:ALEC) Stock Price Up 9% - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

1,959,896 Shares in Alumis Inc. (NASDAQ:ALMS) Bought by SR One Capital Management LP - MarketBeat

Sep 21, 2024
pulisher
Sep 20, 2024

Aileron Therapeutics Inc Inc. (ALRN) Price Performance: The Role of Supply and Demand - The InvestChronicle

Sep 20, 2024
pulisher
Sep 20, 2024

Closing Bell Recap: Aileron Therapeutics Inc (ALRN) Ends at 2.91, Reflecting a 9.81 Upturn - The Dwinnex

Sep 20, 2024
pulisher
Sep 19, 2024

Altair Engineering: Rating Downgrade As Near-Term Upside Is Limited (NASDAQ:ALTR) - Seeking Alpha

Sep 19, 2024
pulisher
Sep 19, 2024

Alumis (NASDAQ:ALMS) Shares Down 2.6% - MarketBeat

Sep 19, 2024
pulisher
Sep 19, 2024

Alesi Surgical wins FDA clearance for smoke management device and lands new funding - Mass Device

Sep 19, 2024
pulisher
Sep 19, 2024

Alector, Inc. (NASDAQ:ALEC) Short Interest Down 5.7% in August - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Allurion Technologies Inc. (NYSE:ALUR) Short Interest Up 8.6% in August - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Australia's ALS tumbles on subdued half-year forecast - XM

Sep 18, 2024
pulisher
Sep 18, 2024

Market cap of Allarity Therapeutics Inc [ALLR] reaches 4.22M – now what? - The DBT News

Sep 18, 2024
pulisher
Sep 18, 2024

Alumis (NASDAQ:ALMS) Stock Price Up 5.3% - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Alexander's (NYSE:ALX) Hits New 52-Week High at $248.10 - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

In the Green: Alector Inc (ALEC) Closes at 5.64, Up/Down -0.70 from Previous Day - The Dwinnex

Sep 18, 2024
pulisher
Sep 18, 2024

Athira shifts focus to ALS drug after Alzheimer’s flop - The Pharma Letter

Sep 18, 2024
pulisher
Sep 18, 2024

Is Alector Inc (ALEC) worth investing in despite its undervalued state? - US Post News

Sep 18, 2024
pulisher
Sep 18, 2024

Alector (NASDAQ:ALEC) Receives Overweight Rating from Cantor Fitzgerald - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

Alimera Sciences completes merger with ANI Pharmaceuticals - Investing.com India

Sep 17, 2024
pulisher
Sep 17, 2024

Altius Minerals (TSE:ALS) Price Target Raised to C$29.00 at Canaccord Genuity Group - Defense World

Sep 17, 2024
pulisher
Sep 17, 2024

Guggenheim raises PT on ANI Pharma after Alimera deal completion - XM

Sep 17, 2024
pulisher
Sep 16, 2024

Alumis (NASDAQ:ALMS) Reaches New 12-Month Low at $10.37 - MarketBeat

Sep 16, 2024
pulisher
Sep 16, 2024

Prepare Yourself for Liftoff: Alector Inc (ALEC) - SETE News

Sep 16, 2024
pulisher
Sep 16, 2024

ANI Pharmaceuticals completes acquisition of Alimera Sciences - TipRanks

Sep 16, 2024
pulisher
Sep 16, 2024

ANI Pharmaceuticals completes purchase of Alimera Sciences (NASDAQ:ALIM) - Seeking Alpha

Sep 16, 2024
pulisher
Sep 16, 2024

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences - GlobeNewswire

Sep 16, 2024
pulisher
Sep 16, 2024

ANI Pharmaceuticals initiates closing of acquisition of Alimera Sciences - TipRanks

Sep 16, 2024

Finanzdaten der Aileron Therapeutics Inc-Aktie (ALRN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Aileron Therapeutics Inc-Aktie (ALRN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
UNIVERSITY OF TEXAS/TEXAS AM I
10% Owner
Jun 14 '24
Sale
3.30
1,900
6,270
1,751,256
UNIVERSITY OF TEXAS/TEXAS AM I
10% Owner
Jun 10 '24
Sale
3.30
9,577
31,604
1,768,250
UNIVERSITY OF TEXAS/TEXAS AM I
10% Owner
Jun 12 '24
Sale
3.25
9,342
30,362
1,753,156
UNIVERSITY OF TEXAS/TEXAS AM I
10% Owner
Jun 11 '24
Sale
3.26
5,752
18,744
1,762,498
UNIVERSITY OF TEXAS/TEXAS AM I
10% Owner
Jun 05 '24
Sale
3.30
6,291
20,760
1,783,851
UNIVERSITY OF TEXAS/TEXAS AM I
10% Owner
Jun 06 '24
Sale
3.29
4,284
14,104
1,779,567
UNIVERSITY OF TEXAS/TEXAS AM I
10% Owner
Jun 07 '24
Sale
3.26
1,740
5,664
1,777,827
UNIVERSITY OF TEXAS/TEXAS AM I
10% Owner
May 01 '24
Sale
4.21
20,315
85,473
1,779,306
UNIVERSITY OF TEXAS/TEXAS AM I
10% Owner
Apr 29 '24
Sale
4.95
10,746
53,182
1,799,711
UNIVERSITY OF TEXAS/TEXAS AM I
10% Owner
Apr 30 '24
Sale
4.97
90
448
1,799,621
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):